[(1R)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;[(1S)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl benzoate;methane;prop-1-ene

C93H138O9 — CID 157423945

IUPAC[(1R)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;[(1S)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl benzoate;methane;prop-1-ene
SMILESC.C.C.C=CC.CC(OC(=O)c1ccccc1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C.C[C@@H](OC(=O)c1ccccc1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C.C[C@H](OC(=O)c1ccccc1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/3C29H40O3.C3H6.3CH4/c3*1-19(32-26(30)20-8-6-5-7-9-20)23-12-13-24-22-11-10-21-18-27(2,31)16-17-28(21,3)25(22)14-15-29(23,24)4;1-3-2;;;/h3*5-10,19,22-25,31H,11-18H2,1-4H3;3H,1H2,2H3;3*1H4/t19?,22-,23+,24-,25-,27-,28-,29+;19-,22+,23-,24+,25+,27+,28+,29-;19-,22-,23+,24-,25-,27-,28-,29+;;;;/m010..../s1
InChIKeyBPSWMBSUMVCOGO-VTZAKVOPSA-N
MW1400.12 g/mol
LogP22.79
Rot. Bonds9

About [(1R)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;[(1S)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl benzoate;methane;prop-1-ene

[(1R)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;[(1S)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl benzoate;methane;prop-1-ene (PubChem CID 157423945) has the molecular formula C93H138O9 and a molecular weight of 1400.12 g/mol. Its IUPAC name is [(1R)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;[(1S)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl benzoate;methane;prop-1-ene.

Molecular Properties

Compound Name[(1R)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;[(1S)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl benzoate;methane;prop-1-ene
PubChem CID157423945
Molecular FormulaC93H138O9
Molecular Weight1400.12 g/mol
Exact Mass1399.03
IUPAC Name[(1R)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;[(1S)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl benzoate;methane;prop-1-ene
SMILESC.C.C.C=CC.CC(OC(=O)c1ccccc1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C.C[C@@H](OC(=O)c1ccccc1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C.C[C@H](OC(=O)c1ccccc1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/3C29H40O3.C3H6.3CH4/c3*1-19(32-26(30)20-8-6-5-7-9-20)23-12-13-24-22-11-10-21-18-27(2,31)16-17-28(21,3)25(22)14-15-29(23,24)4;1-3-2;;;/h3*5-10,19,22-25,31H,11-18H2,1-4H3;3H,1H2,2H3;3*1H4/t19?,22-,23+,24-,25-,27-,28-,29+;19-,22+,23-,24+,25+,27+,28+,29-;19-,22-,23+,24-,25-,27-,28-,29+;;;;/m010..../s1
InChIKeyBPSWMBSUMVCOGO-VTZAKVOPSA-N
XLogP22.79
TPSA139.59 Ų
H-Bond Donors3
H-Bond Acceptors9
Rotatable Bonds9
Heavy Atoms102
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001400.12
LogP ≤ 522.79
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [(1R)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;[(1S)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl benzoate;methane;prop-1-ene with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(1R)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;[(1S)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl benzoate;methane;prop-1-ene?
The IUPAC name of [(1R)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;[(1S)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl benzoate;methane;prop-1-ene (CID 157423945) is [(1R)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;[(1S)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl benzoate;methane;prop-1-ene.
What is the SMILES notation for [(1R)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;[(1S)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl benzoate;methane;prop-1-ene?
The canonical SMILES for [(1R)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;[(1S)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl benzoate;methane;prop-1-ene is C.C.C.C=CC.CC(OC(=O)c1ccccc1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C.C[C@@H](OC(=O)c1ccccc1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C.C[C@H](OC(=O)c1ccccc1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C.
What is the InChIKey of [(1R)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;[(1S)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl benzoate;methane;prop-1-ene?
The InChIKey is BPSWMBSUMVCOGO-VTZAKVOPSA-N. The full InChI is InChI=1S/3C29H40O3.C3H6.3CH4/c3*1-19(32-26(30)20-8-6-5-7-9-20)23-12-13-24-22-11-10-21-18-27(2,31)16-17-28(21,3)25(22)14-15-29(23,24)4;1-3-2;;;/h3*5-10,19,22-25,31H,11-18H2,1-4H3;3H,1H2,2H3;3*1H4/t19?,22-,23+,24-,25-,27-,28-,29+;19-,22+,23-,24+,25+,27+,28+,29-;19-,22-,23+,24-,25-,27-,28-,29+;;;;/m010..../s1.
What are the key properties of [(1R)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;[(1S)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl benzoate;methane;prop-1-ene?
[(1R)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;[(1S)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl benzoate;methane;prop-1-ene has a molecular weight of 1400.12 g/mol, XLogP of 22.79, 9 rotatable bonds, 3 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for [(1R)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;[(1S)-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl] benzoate;1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethyl benzoate;methane;prop-1-ene is sourced from PubChem (CID 157423945), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).